Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Reid RA, Craig EA, Suleman H . Descemet’s membrane endothelial keratoplasty (DMEK): first UK prospective study of 1-year visual outcomes, graft survival and endothelial cell count. Br J Ophthalmol 2015; 99 (2): 166–169.
Price MO, Gorovoy M, Price FW, Benetz BA, Menegay HJ, Lass JH . Descemet’s stripping automated endothelial keratoplasty: three-year graft and endothelial cell survival compared with penetrating keratoplasty. Ophthalmology 2013; 120 (2): 246–251.
Price MO, Price FW . Descemet’s stripping endothelial keratoplasty. Curr Opin Ophthalmol 2007; 18 (4): 290–294.
Anshu A, Price MO, Price FW Jr . Risk of corneal transplant rejection significantly reduced with Descemet’s membrane endothelial keratoplasty. Ophthalmology 2012; 119 (3): 536–540.
Steven P, Hos D, Heindl LM, Bock F, Cursiefen C . Immune reactions after DMEK, DSAEK and DALK. Klin Monbl Augenheilkd 2013; 230 (5): 494–499.
Lapp T, Zaher SS, Haas CT, Becker DL, Thrasivoulou C, Chain BM et al. Identification of therapeutic targets of inflammatory monocyte recruitment to modulate the allogeneic injury to donor cornea. Invest Ophthalmol Vis Sci 2015; 56 (12): 7250–7259.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Lapp, T., Heinzelmann, S., Shanab, W. et al. Graft decentering in DSAEK: a risk factor for immune reactions?. Eye 30, 1147–1149 (2016). https://doi.org/10.1038/eye.2016.76
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2016.76